Renal Cell Cancer

Immuno-Gene Therapy Results Promising in Murine Model

Published in Vaccine Weekly, November 1st, 2000

Transduction of renal cell carcinoma cells with cytokine genes resulted in reduced tumor growth and increased survival in murine models, researchers in Poland reported.

"Renal cell cancer is resistant to all types of therapies," stated P. Wysocki et al. "Immunotherapy based on genetically modified tumor vaccines approaches seem to be a promising treatment of advanced stages of this cancer in patients."

Wysocki et al. presented data from their study at the 14th European Immunology Meeting, held September 23-27, 2000, in Poznan, Poland. The title of their presentation was "Application of cytokine genes in a murine model of renal cell cancer gene...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-11-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry